Ranjan Rajendram
- Ophthalmology top 0.5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Molecular Biology
- Epidemiology
- Biomedical Engineering
- Co-authors
- Catherine EganPhilip HykinRobin HamiltonMichel MichaelidesTünde PetőAndrew KainesFahd QuhillChristopher J. Boos
- Topics
- Retinal Diseases and Treatments (16 papers)Retinal Imaging and Analysis (14 papers)Glaucoma and retinal disorders (7 papers)
- Partner nations
- United KingdomAustriaEgypt
In The Last Decade
Ranjan Rajendram
17 papers receiving 733 citations
Hit Papers
Peers
Comparison fields: 5 of 48
- Ophthalmology 734
- Radiology, Nuclear Medicine and Imaging 664
- Molecular Biology 66
- Epidemiology 22
- Biomedical Engineering 22
Countries citing papers authored by Ranjan Rajendram
This map shows the geographic impact of Ranjan Rajendram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranjan Rajendram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranjan Rajendram more than expected).
Fields of papers citing papers by Ranjan Rajendram
This network shows the impact of papers produced by Ranjan Rajendram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranjan Rajendram. The network helps show where Ranjan Rajendram may publish in the future.
Co-authorship network of co-authors of Ranjan Rajendram
This figure shows the co-authorship network connecting the top 25 collaborators of Ranjan Rajendram. A scholar is included among the top collaborators of Ranjan Rajendram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranjan Rajendram. Ranjan Rajendram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 5 | |
| 6 | 49 | |
| 7 | 22 | |
| 8 | 9 | |
| 9 | 3 | |
| 10 | 21 | |
| 11 | 8 | |
| 12 | 28 | |
| 13 | 19 | |
| 14 | 4 | |
| 15 | 0 | |
| 16 | 65 | |
| 17 | 0 | |
| 18 | 113 | |
| 19 | 17 | |
| 20 | A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)breakdown → | 394 |
About Ranjan Rajendram
Ranjan Rajendram is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 20 papers that have together received 766 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (16 papers), Retinal Imaging and Analysis (14 papers) and Glaucoma and retinal disorders (7 papers). The work is most often cited by research in Ophthalmology (734 citations), Radiology, Nuclear Medicine and Imaging (664 citations) and Clinical Biochemistry (14 citations). Ranjan Rajendram has collaborated with scholars based in United Kingdom, Austria and Egypt. Frequent co-authors include Catherine Egan, Philip Hykin, Robin Hamilton, Michel Michaelides, Tünde Pető, Andrew Kaines, Fahd Quhill, Christopher J. Boos, Samantha Fraser‐Bell and Catey Bunce. Their work appears in journals such as PLoS ONE, Ophthalmology and American Journal of Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.